购物车
您的购物车当前为空
5-HT2A&5-HT2C agonist-2 (Compound 3ci) 是一种高选择性且可透过血脑屏障的双重5-HT2A/5-HT2C激动剂,EC50< 1 μM。该化合物对与心脏瓣膜病风险相关的5-HT2B有高度选择性。它能够诱导头部抽搐反应,但其致幻潜力较低。5-HT2A&5-HT2C agonist-2 可用于抑郁症和肥胖症等疾病的研究。
5-HT2A&5-HT2C agonist-2 (Compound 3ci) 是一种高选择性且可透过血脑屏障的双重5-HT2A/5-HT2C激动剂,EC50< 1 μM。该化合物对与心脏瓣膜病风险相关的5-HT2B有高度选择性。它能够诱导头部抽搐反应,但其致幻潜力较低。5-HT2A&5-HT2C agonist-2 可用于抑郁症和肥胖症等疾病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | 5-HT2A&5-HT2C agonist-2 (Compound 3ci) is a highly selective dual 5-HT2A/5-HT2C agonist capable of crossing the blood-brain barrier, with an EC50 of less than 1 μM. It exhibits strong selectivity against the 5-HT2B receptor, which is associated with the risk of heart valve disease. Although it can induce head twitch responses, its hallucinogenic potential is low. 5-HT2A&5-HT2C agonist-2 is relevant for studying conditions such as depression and obesity. |
| 靶点活性 | 5-HT2A receptor:< 1 μM (EC50) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多